Physician profile
Prashant Shah
NPI 1164605994
$903.98
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.52 · 2021: $45.52 · 2022: $242 · 2023: $209 · 2024: $123 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $252.62 | 2022-2024 | Impella |
| Pylant Medical | $225.42 | 2022-2025 | |
| Atricure, INC. | $164.09 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Zimmer Biomet Holdings, INC. | $95.52 | 2020 | |
| Intuitive Surgical, INC. | $38.08 | 2022 | |
| Ethicon US, LLC | $33.01 | 2023 | Stratafix, Vistaseal, Prolene |
| Pfizer INC. | $27.66 | 2023 | |
| Edwards Lifesciences Corporation | $27.55 | 2023 | |
| Corcym INC | $20.78 | 2023 | Perceval |
| Olympus America INC. | $19.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.